𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Transferrin dependence of Ga(NO3)3 inhibition of growth in human-derived small cell lung cancer cells

✍ Scribed by Ronald E. Weiner; Ingallil Avis; Ronald D. Neumann; James L. Mulshine


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
931 KB
Volume
63
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis


The effect of a combination of anti-transferrin receptor (TFR) antibody, 42/6, and Ga(NO3)3 on cell growth was examined in small cell lung cancer (SCLC) cell lines: classic, NCI-H209, NCI-H345, NCI-H510; and variant, NCI-H82 and NCI-N417. The role of TFR and transferrin (TF) in Ga(NO3)3 cellular uptake was also tested. Exogenous TF did not enhance the cytotoxicity of Ga. At > 3 micrograms/mL, Ga(NO3)3 inhibited growth in all cell lines in TF-supplemented or deficient media. At < 3 micrograms/mL, Ga stimulated growth for all cells but this effect was eliminated by TF or 42/6. Classic SCLC lines required 3-4-fold less exogenous gallium than variant lines to reduce cell number by 50%. The mean Ga uptake (ng/10(6) cells) in H345 and H209 cell lines was 4-5-fold compared to H82 and N417 uptake (P < 0.001). 42/6 reduced exogenous TF-stimulated growth. Antibody plus Ga(NO3)3 caused a slight further cell number decline in all cell lines in TF-supplemented or deficient media. These results suggest that the addition of 42/6 antibody treatment would not increase the effectiveness of Ga(NO3)3 in patients. Both exogenous and endogenous TF and TFR play an important role in Ga uptake in these cells.


πŸ“œ SIMILAR VOLUMES


Human endostatin inhibits growth of huma
✍ Arnd Steffen Boehle; Roland Kurdow; Maren Schulze; Ursula Kliche; Bence Sipos; K πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 261 KB πŸ‘ 1 views

Overall prognosis in human NSCLC remains poor. Antiangiogenic treatment has become a promising concept for the treatment of solid malignancies. Our purpose was to evaluate the efficacy of recombinant HSENDO for the treatment of human NSCLC in an orthotopic murine xenotransplantation model. The effic

Monoclonal antibody Ξ±IR-3 inhibits non-s
✍ Farah Zia; Steve Jacobs; Frederick Kull Jr.; Frank Cuttitta; James L. Mulshine; πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 601 KB

The ability of monoclonal antibody (mAb) alR-3 to interact with non-small cell lung cancer (NSCLC) cells was investigated. MAb alR-3 inhibited specific binding of 1251-IGF-I and 1251-alR-3 to a panel of 8 NSCLC cell lines with high affinity (IC50 = 200 and 50 ng/ml, respectively). 1251-alR-3 bound w

Molecular determinants of UCN-01-induced
✍ Jitsuo Usuda; Nagahiro Saijo; Kazuya Fukuoka; Hisao Fukumoto; Hyo-Jeong Kuh; Tak πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 French βš– 153 KB πŸ‘ 2 views

UCN-01 (7-hydroxystaurosporine) inhibits the growth of various malignant cell lines in vitro and in vivo. In this study, a human small cell lung carcinoma subline resistant to UCN-01, SBC-3/UCN, was established and characterized. SBC-3/ UCN cells showed 8-fold greater resistance to the UCN-01induced

Increased expression of the LGALS3 (Gale
✍ Akinobu Yoshimura; Akihiko Gemma; Yoko Hosoya; Eriko Komaki; Yukio Hosomi; Tetsu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract Patients with lung cancer have a poor prognosis because of the high metastatic potential of the neoplasm. Therefore, identifying new molecular targets for anti‐metastatic therapy is very important. To identify novel key factors of tumor metastasis in lung cancer, we established the gene

p53 cooperates berberine-induced growth
✍ Santosh K. Katiyar; Syed M. Meeran; Nandan Katiyar; Suhail Akhtar πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 537 KB

## Abstract Berberine has been shown to have anti‐carcinogenic effects. Since p53 is the most commonly mutated tumor suppressor gene, and a lack of functional p53 is associated with an increased risk of cancer development, we examined the effects of berberine on p53‐positive and p53‐deficient non‐s

Efficient telomerase inhibition in human
✍ Julia Beisner; Meng Dong; Sebastian Taetz; Kamilla Piotrowska; Elke Kleideiter; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 459 KB πŸ‘ 1 views

The antisense oligonucleotide 2'-O-methyl-RNA is a selective telomerase inhibitor targeting the telomerase RNA component and represents a potential candidate for anticancer therapy. The poor cellular uptake of 2'-O-methyl-RNA is a limiting factor that may contribute to the lack of functional efficac